Process for Accessing Samples from UF Biorepository for COVID-19 Related Research
In partnership with Florida State University (FSU), The University of Florida (UF) will allow access to its biorepository for FSU researchers conducting COVID-19 related research. Access is considered on a case-by-case basis, and is subject to the availability of materials and the review process outlined below.
Currently, the UF Biorepository has over 30,000 samples consisting of EDTA and lithium heparin plasma, some serum and buffy coat samples via the EDTA tubes from over 100 COVID-19 positive and COIVD negative patients. UF is also working on obtaining BAL and tracheal aspirates from COVID19+ patients.